A cost comparison of GLP‐1 receptor agonists and bariatric surgery: what is the break even point?

Año publicación: 2024

Subir documento: https://drive.google.com/file/d/1M8WewsXvnjXjYK518b9cOnOoaxLw4Goj/view?usp=sharing

Nombre investigadores: Salvatore Docimo Jr, Jay Shah, Gus Warren, Samer Ganam, Joseph Sujka, Christopher DuCoin